Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FinlandBack to Finland

Clinical trials in Kotka

4 clinical trials in Kotka, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Kotka at a glance
4
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Kotka

Open in trial search

Dementia

Recruiting

Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

Registered drug
Countries:FinlandFinland
  • Participants:65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:GlaxoSmithKline Biologicals

Colorectal cancer metastatic+1

Recruiting

Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-Yhtymae

Plasma cell myeloma

Recruiting

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.

Infantile spasms

Recruiting

Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Vigabatrin
  • Sponsor:HUS-Yhtymae

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Kotka

What the registry says about research in the country

01 Pediatric Neurology

Groundbreaking research focusing on infantile spasm syndrome prevention in high-risk infants under one year of age. The studies specifically target children with tuberous sclerosis and significant vascular injuries.

  • Early Intervention Strategies
  • Preventive Treatment Approaches
  • Neurological Disorders in Infants

Investigations include assessment of prophylactic medication effectiveness in preventing seizure development.

02 Hematologic Oncology

Advanced clinical research examining innovative combination therapies for multiple myeloma patients who are ineligible for transplantation. The studies evaluate the effectiveness of novel drug combinations including elranatamab.

  • Treatment Optimization
  • Drug Combination Studies
  • Disease Response Assessment

Research focuses on comparing different therapeutic regimens to improve outcomes for newly diagnosed patients.

Back to FinlandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.